Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Linker Pharmaceuticals ApS
APS
Active
Advertising protection
CVR 44308622
Amaliegade 13, 1256
København K
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 2 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Linker Pharmaceuticals ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Income statement
DKK thousands
Item
2024
Gross profit
-13
Staff expenses
-0
EBITDA
-13
Depreciation & amort.
-0
EBIT
-13
Net financials
-2
Profit before tax
-15
Tax
-3
Net profit
-11
Balance sheet
DKK thousands
Item
2024
Total assets
319
Equity
309
Long-term debt
0
Short-term debt
11
Total debt
11
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1271700.0%
This company
2024
2024
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
2024
2024
Return on equity
-3.7%
This company
18.4%
Market median
-120% vs market
2024
2024
Net profit margin (of gross profit)
-1132300.0%
This company
2024
2024
Asset turnover (of gross profit)
-0.04×
This company
2024
2024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-09-15 – 2024-12-31
View
PDF
More on Linker Pharmaceuticals ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
